Last update 20 Mar 2025

Autoimmune diabetes vaccine (Diamyd)

Overview

Basic Info

Drug Type
Therapeutic vaccine, Genetically engineered subunit vaccine
Synonyms
Diabetes-mellitus-vaccine-Diamyd-Medical, Diabetes-mellitus-vaccine-Diamyd-Therapeutics, GAD-Alum vaccine
+ [7]
Target
Action
inhibitors, modulators
Mechanism
GAD2 inhibitors(Glutamate decarboxylase 65 kDa isoform inhibitors), Immunomodulators
Active Indication
Originator Organization
Active Organization
Inactive Organization-
Drug Highest PhasePhase 3
First Approval Date-
RegulationFast Track (United States), Orphan Drug (United States)
Login to view timeline

External Link

KEGGWikiATCDrug Bank
---

R&D Status

10 top R&D records.
Login
to view more data
IndicationHighest PhaseCountry/LocationOrganizationDate
Diabetes Mellitus, Type 1Phase 3
Germany
01 Jul 2008
Diabetes Mellitus, Type 1Phase 3
Sweden
01 Jul 2008
Diabetes Mellitus, Type 1Phase 3
Netherlands
01 Jul 2008
Diabetes Mellitus, Type 1Phase 3
Spain
01 Jul 2008
Diabetes Mellitus, Type 1IND Application
Finland
01 Jul 2008
Diabetes Mellitus, Type 1IND Application
Italy
01 Jul 2008
Diabetes Mellitus, Type 1IND Application
Slovenia
01 Jul 2008
Diabetes Mellitus, Type 1IND Application
United Kingdom
01 Jul 2008
Diabetes Mellitus, Type 1IND Application
France
01 Jul 2008
Latent Autoimmune Diabetes in AdultsPreclinical
Sweden
01 Dec 2004
Login to view more data

Clinical Result

Indication
Phase
Evaluation
View All Results
Study
Phase
PopulationAnalyzed EnrollmentGroupResultsEvaluationPublication Date
Not Applicable
Pancreatic adenocarcinoma
Neoadjuvant | Second line
GAD65 antibody | CA 19-9 | CEA
-
(Pancreatic Adenocarcinoma)
xtijpynfvw(rchkxztzma) = holusdqcpo eohwdbzoqm (lgddasxcsk )
Positive
14 Jun 2024
Phase 2
109
Vitamin D+Diamyd
(Active Arm)
rahichqpjm(eewrymuuxf) = jcnkbclyln oigitwfmzv (opxyweqsuh, fjzelilvid - ptyiveilyr)
-
09 Jan 2023
Placebo for Diamyd
(Placebo Arm)
rahichqpjm(eewrymuuxf) = zehdetvqtk oigitwfmzv (opxyweqsuh, yoyyecaozw - pdjrnyadry)
Phase 1
12
ntiidreaxd(cartcnjnuv) = uyxlrgmumh tvlgiltwtl (mvpbxukcmu, tuvfshdmbg - yhwnnciqcc)
-
27 Apr 2020
Phase 1/2
12
qeoebhoamu(ltppijhbqz) = shjsvkfwnw jhmpmdatmp (htzgvdibkc )
Positive
20 Dec 2019
Phase 2
50
Placebo comparator
(Placebo Comparator)
(urhusrpnej) = xjrveegnww txcvxejjjr (fhlpguubub, ckxlhzzrer - owxhiwqusg)
-
06 May 2019
(Alum-GAD (Diamyd))
(urhusrpnej) = umnnewekaz txcvxejjjr (fhlpguubub, fkyvxqdlbp - dkghpfzplt)
Login to view more data

Translational Medicine

Boost your research with our translational medicine data.
Boost your research with our translational medicine data.

Deal

Boost your decision using our deal data.
Boost your decision using our deal data.

Core Patent

Boost your research with our Core Patent data.
Boost your research with our Core Patent data.

Clinical Trial

Identify the latest clinical trials across global registries.
Identify the latest clinical trials across global registries.

Approval

Accelerate your research with the latest regulatory approval information.
Accelerate your research with the latest regulatory approval information.

Regulation

Understand key drug designations in just a few clicks with Synapse.
Understand key drug designations in just a few clicks with Synapse.
Chat with Hiro
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free